We observed in this study that CDCA8 inhibition blocks AKT/GSK3β/β-catenin signaling in both parental HCC cell culture and CD133+ cell fraction (Figure 7A and Figure 8E). The gene discussed is AKT1; the disease is hepatocellular carcinoma.